Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glaucoma | 127 | 2024 | 1194 | 16.360 |
Why?
|
Glaucoma, Angle-Closure | 98 | 2024 | 192 | 15.130 |
Why?
|
Intraocular Pressure | 151 | 2024 | 1304 | 10.590 |
Why?
|
Glaucoma, Open-Angle | 60 | 2024 | 742 | 6.970 |
Why?
|
Vision Disorders | 56 | 2024 | 1090 | 5.920 |
Why?
|
Refractive Errors | 26 | 2022 | 148 | 5.490 |
Why?
|
Tonometry, Ocular | 46 | 2021 | 238 | 5.290 |
Why?
|
Visual Fields | 68 | 2024 | 1063 | 5.110 |
Why?
|
Visual Acuity | 97 | 2023 | 2714 | 4.860 |
Why?
|
Vision Screening | 18 | 2024 | 72 | 4.720 |
Why?
|
Diagnostic Techniques, Ophthalmological | 19 | 2021 | 252 | 4.420 |
Why?
|
Ocular Hypertension | 31 | 2023 | 211 | 4.360 |
Why?
|
Iris | 44 | 2024 | 232 | 4.160 |
Why?
|
Gonioscopy | 69 | 2024 | 157 | 3.790 |
Why?
|
Iridectomy | 30 | 2024 | 48 | 3.580 |
Why?
|
Visual Field Tests | 33 | 2024 | 415 | 3.330 |
Why?
|
Trabeculectomy | 21 | 2023 | 174 | 3.290 |
Why?
|
Anterior Eye Segment | 34 | 2024 | 144 | 3.240 |
Why?
|
Eyeglasses | 17 | 2022 | 138 | 3.160 |
Why?
|
Vision, Low | 17 | 2024 | 162 | 3.010 |
Why?
|
Cataract Extraction | 23 | 2023 | 464 | 2.940 |
Why?
|
Visually Impaired Persons | 15 | 2020 | 79 | 2.940 |
Why?
|
Homes for the Aged | 9 | 2024 | 273 | 2.850 |
Why?
|
Refraction, Ocular | 21 | 2022 | 188 | 2.830 |
Why?
|
Anterior Chamber | 24 | 2021 | 194 | 2.680 |
Why?
|
Laser Therapy | 27 | 2023 | 1108 | 2.620 |
Why?
|
Optic Nerve Diseases | 17 | 2023 | 342 | 2.430 |
Why?
|
Antihypertensive Agents | 26 | 2019 | 2030 | 2.390 |
Why?
|
Accidental Falls | 18 | 2024 | 1079 | 2.350 |
Why?
|
Tomography, Optical Coherence | 70 | 2024 | 2954 | 2.300 |
Why?
|
Eye Diseases | 17 | 2021 | 660 | 2.120 |
Why?
|
Cataract | 21 | 2023 | 837 | 2.050 |
Why?
|
Pupil | 13 | 2019 | 147 | 1.970 |
Why?
|
Blindness | 20 | 2023 | 585 | 1.890 |
Why?
|
Ophthalmology | 16 | 2024 | 560 | 1.880 |
Why?
|
Reflex, Pupillary | 5 | 2019 | 63 | 1.690 |
Why?
|
Diabetic Retinopathy | 14 | 2020 | 1300 | 1.670 |
Why?
|
Trabecular Meshwork | 17 | 2018 | 101 | 1.540 |
Why?
|
Rural Population | 27 | 2020 | 2321 | 1.540 |
Why?
|
Patient Compliance | 14 | 2019 | 2697 | 1.480 |
Why?
|
Lasers, Solid-State | 10 | 2022 | 183 | 1.450 |
Why?
|
Baltimore | 16 | 2022 | 233 | 1.430 |
Why?
|
Cloprostenol | 7 | 2013 | 21 | 1.400 |
Why?
|
Phacoemulsification | 8 | 2023 | 151 | 1.400 |
Why?
|
Myopia | 10 | 2023 | 254 | 1.400 |
Why?
|
Ophthalmic Solutions | 11 | 2015 | 312 | 1.280 |
Why?
|
Optic Disk | 17 | 2023 | 421 | 1.270 |
Why?
|
Chloral Hydrate | 2 | 2018 | 28 | 1.240 |
Why?
|
Aged | 217 | 2024 | 171319 | 1.190 |
Why?
|
Lens, Crystalline | 8 | 2022 | 387 | 1.170 |
Why?
|
Cross-Sectional Studies | 100 | 2024 | 26325 | 1.160 |
Why?
|
China | 45 | 2024 | 2394 | 1.150 |
Why?
|
Mydriasis | 3 | 2024 | 13 | 1.140 |
Why?
|
Photography | 13 | 2017 | 536 | 1.080 |
Why?
|
Fear | 9 | 2024 | 1496 | 1.050 |
Why?
|
Prospective Studies | 96 | 2024 | 54886 | 1.040 |
Why?
|
Humans | 387 | 2024 | 767040 | 1.030 |
Why?
|
India | 19 | 2024 | 2334 | 1.030 |
Why?
|
Middle Aged | 214 | 2024 | 223233 | 1.030 |
Why?
|
Male | 272 | 2024 | 364203 | 1.030 |
Why?
|
Vision Tests | 9 | 2020 | 160 | 1.020 |
Why?
|
Female | 279 | 2024 | 396660 | 1.010 |
Why?
|
Medicare Part B | 4 | 2014 | 116 | 0.980 |
Why?
|
Prevalence | 63 | 2024 | 15851 | 0.980 |
Why?
|
Urban Population | 12 | 2018 | 2044 | 0.980 |
Why?
|
Drug Monitoring | 6 | 2014 | 963 | 0.930 |
Why?
|
Retinal Ganglion Cells | 6 | 2023 | 810 | 0.920 |
Why?
|
Conscious Sedation | 2 | 2018 | 534 | 0.880 |
Why?
|
Reminder Systems | 3 | 2019 | 389 | 0.860 |
Why?
|
Sickness Impact Profile | 10 | 2020 | 299 | 0.850 |
Why?
|
Maryland | 16 | 2018 | 277 | 0.820 |
Why?
|
Schools | 8 | 2022 | 1498 | 0.820 |
Why?
|
Medication Adherence | 8 | 2019 | 2191 | 0.810 |
Why?
|
Microscopy, Acoustic | 7 | 2013 | 47 | 0.810 |
Why?
|
Monitoring, Ambulatory | 2 | 2021 | 357 | 0.790 |
Why?
|
Aged, 80 and over | 95 | 2024 | 59548 | 0.790 |
Why?
|
Pupil Disorders | 3 | 2022 | 33 | 0.770 |
Why?
|
Accidents, Home | 2 | 2019 | 73 | 0.760 |
Why?
|
Health Services | 6 | 2019 | 755 | 0.760 |
Why?
|
Biometry | 22 | 2023 | 571 | 0.750 |
Why?
|
Nerve Fibers | 4 | 2023 | 706 | 0.750 |
Why?
|
Corneal Wavefront Aberration | 1 | 2021 | 7 | 0.750 |
Why?
|
Aberrometry | 1 | 2021 | 8 | 0.740 |
Why?
|
Diabetes Complications | 5 | 2016 | 1319 | 0.730 |
Why?
|
Appointments and Schedules | 2 | 2021 | 443 | 0.700 |
Why?
|
Distance Perception | 1 | 2020 | 18 | 0.690 |
Why?
|
Age Distribution | 24 | 2024 | 2870 | 0.690 |
Why?
|
Hypnotics and Sedatives | 2 | 2018 | 1193 | 0.690 |
Why?
|
Reading | 7 | 2021 | 541 | 0.690 |
Why?
|
Lens Implantation, Intraocular | 9 | 2020 | 192 | 0.680 |
Why?
|
Lighting | 2 | 2021 | 210 | 0.680 |
Why?
|
Nutrition Surveys | 8 | 2024 | 1738 | 0.670 |
Why?
|
Telemetry | 1 | 2021 | 201 | 0.670 |
Why?
|
Cornea | 13 | 2023 | 1316 | 0.660 |
Why?
|
Limbus Corneae | 1 | 2021 | 144 | 0.660 |
Why?
|
Prostaglandins F, Synthetic | 5 | 2014 | 32 | 0.660 |
Why?
|
Conjunctiva | 3 | 2019 | 477 | 0.660 |
Why?
|
Sex Distribution | 21 | 2024 | 2276 | 0.640 |
Why?
|
Health Services Accessibility | 12 | 2022 | 5519 | 0.630 |
Why?
|
Allied Health Personnel | 1 | 2020 | 156 | 0.630 |
Why?
|
Dark Adaptation | 2 | 2019 | 224 | 0.610 |
Why?
|
Fluocinolone Acetonide | 2 | 2020 | 38 | 0.600 |
Why?
|
Exercise | 13 | 2024 | 5954 | 0.590 |
Why?
|
Community Health Services | 4 | 2021 | 659 | 0.590 |
Why?
|
Macular Degeneration | 12 | 2018 | 1015 | 0.580 |
Why?
|
Risk Factors | 70 | 2024 | 74886 | 0.560 |
Why?
|
Hyperopia | 4 | 2022 | 41 | 0.560 |
Why?
|
Morbidity | 7 | 2020 | 1754 | 0.560 |
Why?
|
Singapore | 20 | 2021 | 300 | 0.550 |
Why?
|
Reference Standards | 1 | 2020 | 1011 | 0.550 |
Why?
|
Surgical Stomas | 1 | 2016 | 45 | 0.530 |
Why?
|
Disability Evaluation | 5 | 2020 | 1829 | 0.520 |
Why?
|
Adult | 103 | 2024 | 223317 | 0.520 |
Why?
|
Ophthalmologic Surgical Procedures | 4 | 2022 | 354 | 0.520 |
Why?
|
ROC Curve | 17 | 2024 | 3618 | 0.510 |
Why?
|
Telemedicine | 7 | 2021 | 3110 | 0.500 |
Why?
|
Mass Screening | 7 | 2024 | 5456 | 0.490 |
Why?
|
Quality of Life | 22 | 2023 | 13485 | 0.490 |
Why?
|
Reproducibility of Results | 29 | 2023 | 20169 | 0.490 |
Why?
|
Glaucoma Drainage Implants | 3 | 2023 | 107 | 0.460 |
Why?
|
Counseling | 2 | 2021 | 1553 | 0.450 |
Why?
|
Telecommunications | 1 | 2014 | 79 | 0.450 |
Why?
|
Mobility Limitation | 1 | 2018 | 409 | 0.440 |
Why?
|
Ambulatory Care Facilities | 2 | 2022 | 939 | 0.440 |
Why?
|
Contrast Sensitivity | 7 | 2019 | 253 | 0.430 |
Why?
|
Automobile Driving | 5 | 2020 | 442 | 0.430 |
Why?
|
Independent Living | 1 | 2018 | 584 | 0.430 |
Why?
|
Nursing Homes | 4 | 2005 | 1084 | 0.430 |
Why?
|
Medicare Part A | 1 | 2013 | 40 | 0.420 |
Why?
|
Blood Pressure | 7 | 2019 | 8531 | 0.420 |
Why?
|
Follow-Up Studies | 38 | 2024 | 39317 | 0.420 |
Why?
|
Retina | 5 | 2023 | 2659 | 0.410 |
Why?
|
Patient Education as Topic | 7 | 2019 | 2337 | 0.410 |
Why?
|
False Positive Reactions | 9 | 2020 | 959 | 0.410 |
Why?
|
Axial Length, Eye | 7 | 2019 | 36 | 0.400 |
Why?
|
Managed Care Programs | 4 | 2008 | 939 | 0.400 |
Why?
|
Physical Examination | 1 | 2018 | 1265 | 0.390 |
Why?
|
Computers, Handheld | 1 | 2014 | 211 | 0.390 |
Why?
|
Motor Activity | 5 | 2019 | 2713 | 0.390 |
Why?
|
Activities of Daily Living | 7 | 2020 | 2429 | 0.380 |
Why?
|
Travel | 3 | 2015 | 805 | 0.380 |
Why?
|
Insurance Benefits | 1 | 2013 | 185 | 0.380 |
Why?
|
Patient Satisfaction | 11 | 2022 | 3488 | 0.370 |
Why?
|
Mydriatics | 5 | 2022 | 67 | 0.360 |
Why?
|
Retinal Diseases | 3 | 2012 | 709 | 0.360 |
Why?
|
Sensitivity and Specificity | 17 | 2021 | 14672 | 0.360 |
Why?
|
United States | 40 | 2024 | 72971 | 0.360 |
Why?
|
Amblyopia | 2 | 2010 | 152 | 0.360 |
Why?
|
Program Evaluation | 2 | 2022 | 2505 | 0.340 |
Why?
|
Health Knowledge, Attitudes, Practice | 8 | 2020 | 4054 | 0.340 |
Why?
|
Sclera | 5 | 2016 | 189 | 0.340 |
Why?
|
Physician-Patient Relations | 5 | 2015 | 3266 | 0.340 |
Why?
|
Attitude to Health | 5 | 2011 | 2023 | 0.330 |
Why?
|
Retrospective Studies | 46 | 2024 | 81659 | 0.330 |
Why?
|
Administration, Topical | 7 | 2015 | 703 | 0.330 |
Why?
|
Uveitis | 1 | 2013 | 398 | 0.320 |
Why?
|
Geographic Information Systems | 1 | 2011 | 283 | 0.320 |
Why?
|
Health Surveys | 11 | 2018 | 4056 | 0.320 |
Why?
|
Medically Underserved Area | 1 | 2011 | 268 | 0.310 |
Why?
|
Glucocorticoids | 2 | 2020 | 2163 | 0.310 |
Why?
|
Patient Acceptance of Health Care | 5 | 2019 | 3232 | 0.300 |
Why?
|
Eye Injuries | 3 | 2021 | 228 | 0.300 |
Why?
|
Triglycerides | 1 | 2016 | 2444 | 0.300 |
Why?
|
Pseudophakia | 4 | 2020 | 61 | 0.300 |
Why?
|
Actigraphy | 1 | 2012 | 527 | 0.300 |
Why?
|
Area Under Curve | 11 | 2024 | 1639 | 0.290 |
Why?
|
Vulnerable Populations | 1 | 2013 | 718 | 0.290 |
Why?
|
Drug Utilization Review | 2 | 2008 | 248 | 0.280 |
Why?
|
Fundus Oculi | 3 | 2019 | 560 | 0.280 |
Why?
|
Dyslexia | 1 | 2009 | 215 | 0.280 |
Why?
|
Strabismus | 3 | 2012 | 320 | 0.280 |
Why?
|
Insurance Claim Review | 3 | 2008 | 744 | 0.280 |
Why?
|
Vision, Ocular | 4 | 2019 | 457 | 0.270 |
Why?
|
Fixation, Ocular | 1 | 2008 | 243 | 0.270 |
Why?
|
Reoperation | 5 | 2021 | 4325 | 0.260 |
Why?
|
Eye Abnormalities | 2 | 2023 | 243 | 0.260 |
Why?
|
Evidence-Based Medicine | 7 | 2017 | 3700 | 0.260 |
Why?
|
Insurance, Major Medical | 1 | 2005 | 12 | 0.260 |
Why?
|
Models, Statistical | 5 | 2013 | 5098 | 0.260 |
Why?
|
Disease Progression | 16 | 2024 | 13646 | 0.260 |
Why?
|
Child | 25 | 2023 | 80771 | 0.260 |
Why?
|
Drug Utilization | 4 | 2015 | 1190 | 0.250 |
Why?
|
Ciliary Body | 6 | 2021 | 168 | 0.250 |
Why?
|
Health Services for the Aged | 2 | 2005 | 264 | 0.250 |
Why?
|
Acute Disease | 9 | 2023 | 7236 | 0.250 |
Why?
|
Health Insurance Portability and Accountability Act | 1 | 2006 | 105 | 0.250 |
Why?
|
Universities | 1 | 2011 | 1004 | 0.250 |
Why?
|
Dementia | 1 | 2020 | 2741 | 0.250 |
Why?
|
Family Health | 4 | 2021 | 1254 | 0.250 |
Why?
|
Healthcare Disparities | 4 | 2021 | 3414 | 0.240 |
Why?
|
Educational Status | 7 | 2022 | 2511 | 0.240 |
Why?
|
Operating Rooms | 3 | 2021 | 790 | 0.230 |
Why?
|
Low Tension Glaucoma | 1 | 2024 | 24 | 0.230 |
Why?
|
Child, Preschool | 14 | 2024 | 42606 | 0.230 |
Why?
|
Astigmatism | 3 | 2021 | 69 | 0.230 |
Why?
|
Population Surveillance | 4 | 2021 | 2594 | 0.230 |
Why?
|
Diabetes Mellitus | 7 | 2020 | 5886 | 0.220 |
Why?
|
Young Adult | 17 | 2023 | 59980 | 0.220 |
Why?
|
Hypertension | 4 | 2020 | 8615 | 0.220 |
Why?
|
Cell Count | 3 | 2019 | 1825 | 0.220 |
Why?
|
Movement Disorders | 1 | 2007 | 462 | 0.220 |
Why?
|
Bangladesh | 2 | 2019 | 742 | 0.220 |
Why?
|
Cohort Studies | 19 | 2024 | 41718 | 0.220 |
Why?
|
Predictive Value of Tests | 12 | 2024 | 15424 | 0.220 |
Why?
|
Blister | 3 | 2009 | 88 | 0.210 |
Why?
|
Risk Assessment | 13 | 2024 | 24299 | 0.210 |
Why?
|
Smoking | 3 | 2019 | 9081 | 0.210 |
Why?
|
Adolescent | 17 | 2023 | 89046 | 0.210 |
Why?
|
Laser Coagulation | 2 | 2016 | 335 | 0.210 |
Why?
|
Physicians | 1 | 2020 | 4593 | 0.200 |
Why?
|
Vision, Binocular | 4 | 2013 | 225 | 0.200 |
Why?
|
Patient-Centered Care | 2 | 2010 | 1444 | 0.200 |
Why?
|
Communication | 4 | 2015 | 3904 | 0.200 |
Why?
|
Presbyopia | 1 | 2022 | 10 | 0.200 |
Why?
|
Incidence | 15 | 2021 | 21526 | 0.200 |
Why?
|
Emergency Service, Hospital | 4 | 2021 | 7871 | 0.200 |
Why?
|
Manufactured Materials | 3 | 2012 | 18 | 0.200 |
Why?
|
Drug Packaging | 2 | 2015 | 44 | 0.200 |
Why?
|
Oxygen Consumption | 2 | 2018 | 1873 | 0.190 |
Why?
|
Drug Prescriptions | 3 | 2007 | 1664 | 0.190 |
Why?
|
School Nursing | 1 | 2021 | 34 | 0.190 |
Why?
|
Age Factors | 11 | 2020 | 18401 | 0.190 |
Why?
|
Eye | 3 | 2010 | 711 | 0.190 |
Why?
|
Phenylephrine | 1 | 2022 | 292 | 0.190 |
Why?
|
Developing Countries | 2 | 2011 | 2911 | 0.190 |
Why?
|
Choroid | 3 | 2014 | 364 | 0.180 |
Why?
|
Health Promotion | 3 | 2022 | 2210 | 0.180 |
Why?
|
Electronic Health Records | 4 | 2024 | 4881 | 0.180 |
Why?
|
Health Care Costs | 2 | 2013 | 3239 | 0.180 |
Why?
|
Gait | 3 | 2021 | 823 | 0.180 |
Why?
|
Odds Ratio | 8 | 2019 | 9660 | 0.180 |
Why?
|
Uveitis, Intermediate | 1 | 2020 | 17 | 0.180 |
Why?
|
Exfoliation Syndrome | 3 | 2018 | 113 | 0.180 |
Why?
|
Aging | 6 | 2018 | 8729 | 0.170 |
Why?
|
Uveitis, Posterior | 1 | 2020 | 45 | 0.170 |
Why?
|
Filtering Surgery | 2 | 2015 | 34 | 0.170 |
Why?
|
Panuveitis | 1 | 2020 | 33 | 0.170 |
Why?
|
Light | 6 | 2012 | 1358 | 0.170 |
Why?
|
Hospitals, Special | 1 | 2020 | 89 | 0.170 |
Why?
|
Siblings | 3 | 2021 | 828 | 0.170 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2021 | 10393 | 0.170 |
Why?
|
Color Vision | 1 | 2019 | 23 | 0.170 |
Why?
|
Economics, Medical | 1 | 2020 | 112 | 0.170 |
Why?
|
Video Recording | 5 | 2012 | 977 | 0.170 |
Why?
|
Suture Techniques | 2 | 2019 | 775 | 0.160 |
Why?
|
Lenses, Intraocular | 2 | 2019 | 141 | 0.160 |
Why?
|
Psychomotor Performance | 1 | 2007 | 1886 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2018 | 16036 | 0.160 |
Why?
|
Treatment Outcome | 21 | 2023 | 65295 | 0.160 |
Why?
|
Functional Laterality | 4 | 2010 | 2245 | 0.150 |
Why?
|
Biomedical Technology | 1 | 2021 | 210 | 0.150 |
Why?
|
Artificial Intelligence | 3 | 2023 | 2666 | 0.150 |
Why?
|
Hospitals, Rural | 3 | 2015 | 174 | 0.150 |
Why?
|
Infant | 10 | 2021 | 36485 | 0.150 |
Why?
|
Manometry | 1 | 2020 | 458 | 0.150 |
Why?
|
Prone Position | 1 | 2019 | 203 | 0.150 |
Why?
|
Optometry | 1 | 2017 | 29 | 0.150 |
Why?
|
Intention to Treat Analysis | 1 | 2019 | 418 | 0.150 |
Why?
|
School Health Services | 1 | 2021 | 388 | 0.150 |
Why?
|
Drug Implants | 2 | 2020 | 230 | 0.140 |
Why?
|
Postal Service | 1 | 2017 | 96 | 0.140 |
Why?
|
Self Report | 2 | 2020 | 3773 | 0.140 |
Why?
|
Prescriptions | 2 | 2017 | 388 | 0.140 |
Why?
|
Genome-Wide Association Study | 6 | 2024 | 12790 | 0.140 |
Why?
|
Observer Variation | 9 | 2019 | 2616 | 0.140 |
Why?
|
Parents | 4 | 2021 | 3594 | 0.140 |
Why?
|
Databases, Factual | 8 | 2020 | 8068 | 0.140 |
Why?
|
Quality Assurance, Health Care | 2 | 2019 | 2174 | 0.140 |
Why?
|
Delaware | 3 | 2005 | 13 | 0.140 |
Why?
|
Trust | 1 | 2021 | 532 | 0.140 |
Why?
|
Longitudinal Studies | 11 | 2023 | 14766 | 0.140 |
Why?
|
Heart Rate | 2 | 2018 | 4209 | 0.130 |
Why?
|
Monitoring, Physiologic | 2 | 2016 | 1794 | 0.130 |
Why?
|
Referral and Consultation | 3 | 2024 | 3618 | 0.130 |
Why?
|
Logistic Models | 4 | 2024 | 13284 | 0.130 |
Why?
|
Sex Factors | 9 | 2020 | 10622 | 0.130 |
Why?
|
Research Design | 6 | 2017 | 6210 | 0.130 |
Why?
|
Self Care | 1 | 2021 | 800 | 0.120 |
Why?
|
Insurance, Health | 3 | 2018 | 2519 | 0.120 |
Why?
|
Postural Balance | 1 | 2020 | 638 | 0.120 |
Why?
|
Postoperative Complications | 8 | 2023 | 15824 | 0.120 |
Why?
|
Scotoma | 1 | 2016 | 128 | 0.120 |
Why?
|
Fluorouracil | 3 | 2016 | 1652 | 0.120 |
Why?
|
Case-Control Studies | 10 | 2021 | 22254 | 0.120 |
Why?
|
Diagnostic Self Evaluation | 1 | 2016 | 228 | 0.110 |
Why?
|
Therapies, Investigational | 1 | 2015 | 110 | 0.110 |
Why?
|
Interferometry | 2 | 2012 | 101 | 0.110 |
Why?
|
Photic Stimulation | 2 | 2013 | 1989 | 0.110 |
Why?
|
Equipment Safety | 1 | 2015 | 250 | 0.110 |
Why?
|
Caveolin 2 | 1 | 2013 | 25 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2020 | 1396 | 0.110 |
Why?
|
Wnt Proteins | 1 | 2018 | 723 | 0.110 |
Why?
|
Geographic Atrophy | 1 | 2015 | 92 | 0.110 |
Why?
|
Double-Blind Method | 4 | 2013 | 12451 | 0.110 |
Why?
|
Clinical Competence | 3 | 2015 | 4859 | 0.110 |
Why?
|
Keratoconus | 1 | 2015 | 112 | 0.110 |
Why?
|
Injections | 1 | 2016 | 839 | 0.110 |
Why?
|
Reflex, Abnormal | 1 | 2013 | 83 | 0.110 |
Why?
|
Pterygium | 1 | 2013 | 24 | 0.110 |
Why?
|
Genomic Structural Variation | 1 | 2013 | 80 | 0.110 |
Why?
|
Needles | 1 | 2016 | 461 | 0.110 |
Why?
|
Probability | 3 | 2013 | 2476 | 0.110 |
Why?
|
Time Factors | 14 | 2020 | 40154 | 0.110 |
Why?
|
Obesity, Abdominal | 1 | 2016 | 373 | 0.100 |
Why?
|
Medical Record Linkage | 1 | 2014 | 286 | 0.100 |
Why?
|
Comparative Effectiveness Research | 2 | 2015 | 713 | 0.100 |
Why?
|
Wet Macular Degeneration | 1 | 2015 | 165 | 0.100 |
Why?
|
Child Health Services | 1 | 2018 | 645 | 0.100 |
Why?
|
Nystagmus, Congenital | 1 | 2012 | 9 | 0.100 |
Why?
|
Lens Diseases | 1 | 2012 | 13 | 0.100 |
Why?
|
Lacrimal Apparatus Diseases | 1 | 2013 | 72 | 0.100 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 677 | 0.100 |
Why?
|
False Negative Reactions | 1 | 2013 | 570 | 0.100 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2012 | 122 | 0.100 |
Why?
|
Caveolin 1 | 1 | 2013 | 255 | 0.100 |
Why?
|
Cell Size | 1 | 2013 | 624 | 0.090 |
Why?
|
United States Department of Veterans Affairs | 1 | 2016 | 937 | 0.090 |
Why?
|
Amides | 2 | 2011 | 451 | 0.090 |
Why?
|
Hearing Loss | 1 | 2018 | 785 | 0.090 |
Why?
|
Students | 3 | 2021 | 1744 | 0.090 |
Why?
|
Cross-Cultural Comparison | 1 | 2014 | 638 | 0.090 |
Why?
|
Health Services Research | 3 | 2007 | 1815 | 0.090 |
Why?
|
Education, Medical, Graduate | 2 | 2013 | 2420 | 0.090 |
Why?
|
Hospitals | 2 | 2022 | 3883 | 0.090 |
Why?
|
Health Behavior | 2 | 2014 | 2650 | 0.090 |
Why?
|
Multivariate Analysis | 5 | 2019 | 12069 | 0.090 |
Why?
|
New York City | 2 | 2024 | 736 | 0.090 |
Why?
|
Biomedical Research | 1 | 2006 | 3464 | 0.090 |
Why?
|
Endothelium, Corneal | 1 | 2012 | 212 | 0.090 |
Why?
|
Scattering, Radiation | 1 | 2012 | 486 | 0.090 |
Why?
|
Administration, Oral | 1 | 2018 | 4026 | 0.090 |
Why?
|
Treatment Failure | 1 | 2016 | 2658 | 0.090 |
Why?
|
Hypotension | 1 | 2016 | 888 | 0.080 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1660 | 0.080 |
Why?
|
Surgically-Created Structures | 1 | 2009 | 9 | 0.080 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 2131 | 0.080 |
Why?
|
Regression Analysis | 3 | 2013 | 6331 | 0.080 |
Why?
|
Medicare | 3 | 2023 | 6813 | 0.080 |
Why?
|
Algorithms | 6 | 2023 | 14098 | 0.080 |
Why?
|
Attitude of Health Personnel | 2 | 2021 | 3928 | 0.080 |
Why?
|
Retinal Vessels | 1 | 2015 | 863 | 0.080 |
Why?
|
Rural Health Services | 1 | 2013 | 393 | 0.080 |
Why?
|
Epidemiologic Methods | 2 | 2015 | 1326 | 0.080 |
Why?
|
Lasers | 2 | 2023 | 951 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1882 | 0.080 |
Why?
|
Macula Lutea | 1 | 2010 | 180 | 0.080 |
Why?
|
Eyelids | 1 | 2011 | 278 | 0.080 |
Why?
|
Prostaglandins, Synthetic | 1 | 2008 | 24 | 0.080 |
Why?
|
Focus Groups | 3 | 2021 | 1460 | 0.080 |
Why?
|
Epiretinal Membrane | 1 | 2008 | 73 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6513 | 0.080 |
Why?
|
Severity of Illness Index | 4 | 2016 | 15925 | 0.080 |
Why?
|
Efficiency, Organizational | 1 | 2013 | 697 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2017 | 8940 | 0.070 |
Why?
|
Movement | 1 | 2015 | 1473 | 0.070 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1465 | 0.070 |
Why?
|
Body Height | 1 | 2014 | 1565 | 0.070 |
Why?
|
Nerve Degeneration | 1 | 2012 | 748 | 0.070 |
Why?
|
Iris Diseases | 1 | 2007 | 36 | 0.070 |
Why?
|
Minority Groups | 1 | 2015 | 1214 | 0.070 |
Why?
|
Body Mass Index | 3 | 2016 | 13048 | 0.070 |
Why?
|
Corneal Diseases | 1 | 2013 | 535 | 0.070 |
Why?
|
Consensus | 1 | 2017 | 3207 | 0.070 |
Why?
|
Income | 1 | 2016 | 1877 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2018 | 2780 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2019 | 2085 | 0.070 |
Why?
|
Health Status Indicators | 1 | 2012 | 969 | 0.070 |
Why?
|
Blood Glucose | 4 | 2014 | 6421 | 0.070 |
Why?
|
United States Food and Drug Administration | 1 | 2015 | 1672 | 0.070 |
Why?
|
Estrogens | 1 | 2013 | 1536 | 0.070 |
Why?
|
Nuclear Family | 1 | 2007 | 311 | 0.070 |
Why?
|
Ultrasonography | 6 | 2021 | 6000 | 0.070 |
Why?
|
Decision Making | 2 | 2019 | 3951 | 0.070 |
Why?
|
Chronic Disease | 1 | 2021 | 9362 | 0.060 |
Why?
|
Mitomycin | 2 | 2023 | 261 | 0.060 |
Why?
|
Adiposity | 1 | 2016 | 1894 | 0.060 |
Why?
|
Geriatric Assessment | 2 | 2014 | 1422 | 0.060 |
Why?
|
Asia | 3 | 2015 | 629 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1405 | 0.060 |
Why?
|
Organ Size | 3 | 2018 | 2264 | 0.060 |
Why?
|
Medicaid | 1 | 2018 | 2836 | 0.060 |
Why?
|
Education, Medical, Continuing | 1 | 2010 | 829 | 0.060 |
Why?
|
Intelligence Tests | 1 | 2005 | 504 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 1995 | 0.060 |
Why?
|
Circadian Rhythm | 2 | 2016 | 2591 | 0.060 |
Why?
|
Exercise Test | 1 | 2012 | 2188 | 0.060 |
Why?
|
Aphakia, Postcataract | 1 | 2004 | 52 | 0.060 |
Why?
|
Miotics | 1 | 2003 | 9 | 0.050 |
Why?
|
Specialization | 1 | 2008 | 778 | 0.050 |
Why?
|
Uvea | 1 | 2003 | 31 | 0.050 |
Why?
|
Pilocarpine | 1 | 2003 | 64 | 0.050 |
Why?
|
Body Weight | 1 | 2014 | 4627 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 3 | 2013 | 18063 | 0.050 |
Why?
|
Republic of Korea | 2 | 2016 | 591 | 0.050 |
Why?
|
Thailand | 1 | 2023 | 288 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2013 | 2647 | 0.050 |
Why?
|
Glucose | 1 | 2014 | 4341 | 0.050 |
Why?
|
Veterans | 1 | 2016 | 2666 | 0.050 |
Why?
|
Postoperative Period | 3 | 2017 | 1824 | 0.050 |
Why?
|
Photophobia | 1 | 2023 | 77 | 0.050 |
Why?
|
Publications | 1 | 2004 | 195 | 0.050 |
Why?
|
Primary Health Care | 1 | 2019 | 4746 | 0.050 |
Why?
|
Developmental Disabilities | 1 | 2011 | 1518 | 0.050 |
Why?
|
Fourier Analysis | 2 | 2013 | 435 | 0.050 |
Why?
|
Equipment Design | 1 | 2010 | 3489 | 0.050 |
Why?
|
Reference Values | 3 | 2015 | 4918 | 0.050 |
Why?
|
Prognosis | 6 | 2018 | 29963 | 0.050 |
Why?
|
Hemorrhage | 2 | 2024 | 3464 | 0.050 |
Why?
|
Chicago | 1 | 2022 | 255 | 0.050 |
Why?
|
Cluster Analysis | 2 | 2024 | 2721 | 0.050 |
Why?
|
Causality | 2 | 2004 | 1253 | 0.050 |
Why?
|
Comorbidity | 3 | 2021 | 10582 | 0.050 |
Why?
|
Anisometropia | 2 | 2011 | 17 | 0.050 |
Why?
|
World Health Organization | 2 | 2022 | 1327 | 0.050 |
Why?
|
Hospitalization | 1 | 2020 | 10815 | 0.040 |
Why?
|
Health Expenditures | 1 | 2013 | 2390 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2012 | 534 | 0.040 |
Why?
|
Medicine | 1 | 2008 | 944 | 0.040 |
Why?
|
Drug Therapy | 1 | 2003 | 504 | 0.040 |
Why?
|
Weather | 1 | 2021 | 234 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2020 | 26396 | 0.040 |
Why?
|
Residential Facilities | 1 | 2019 | 41 | 0.040 |
Why?
|
Motivation | 1 | 2009 | 2021 | 0.040 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 4401 | 0.040 |
Why?
|
Optic Nerve | 2 | 2013 | 568 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2022 | 751 | 0.040 |
Why?
|
Patient Care | 1 | 2004 | 628 | 0.040 |
Why?
|
Guideline Adherence | 2 | 2007 | 2232 | 0.040 |
Why?
|
Prosthesis Implantation | 1 | 2023 | 594 | 0.040 |
Why?
|
Genotype | 4 | 2013 | 13035 | 0.040 |
Why?
|
Prostaglandins | 2 | 2013 | 398 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2024 | 787 | 0.040 |
Why?
|
Dilatation, Pathologic | 2 | 2010 | 527 | 0.040 |
Why?
|
International Classification of Diseases | 1 | 2024 | 935 | 0.040 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 5537 | 0.040 |
Why?
|
Vitreous Body | 1 | 2020 | 401 | 0.040 |
Why?
|
Hospital Charges | 1 | 2020 | 345 | 0.040 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5363 | 0.040 |
Why?
|
Microscopy | 1 | 2003 | 903 | 0.040 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 8048 | 0.040 |
Why?
|
Spinal Cord Diseases | 1 | 2020 | 291 | 0.040 |
Why?
|
Hearing Tests | 1 | 2018 | 123 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 891 | 0.040 |
Why?
|
Linear Models | 2 | 2021 | 5875 | 0.040 |
Why?
|
Quality Improvement | 1 | 2013 | 3854 | 0.040 |
Why?
|
Quality of Health Care | 3 | 2021 | 4306 | 0.040 |
Why?
|
Alleles | 3 | 2013 | 6893 | 0.040 |
Why?
|
Pandemics | 3 | 2021 | 8736 | 0.030 |
Why?
|
Advisory Committees | 1 | 2021 | 797 | 0.030 |
Why?
|
Neurotoxicity Syndromes | 1 | 2020 | 302 | 0.030 |
Why?
|
Family | 1 | 2007 | 3210 | 0.030 |
Why?
|
Lightning | 1 | 2015 | 4 | 0.030 |
Why?
|
Color Perception Tests | 1 | 2015 | 12 | 0.030 |
Why?
|
Educational Measurement | 2 | 2013 | 1259 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2024 | 1422 | 0.030 |
Why?
|
Europe | 2 | 2018 | 3432 | 0.030 |
Why?
|
Pacific Islands | 1 | 2015 | 52 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7848 | 0.030 |
Why?
|
Darkness | 1 | 2015 | 159 | 0.030 |
Why?
|
Introns | 1 | 2018 | 965 | 0.030 |
Why?
|
Seasons | 1 | 2021 | 1523 | 0.030 |
Why?
|
Automation | 1 | 2017 | 587 | 0.030 |
Why?
|
Developed Countries | 1 | 2018 | 453 | 0.030 |
Why?
|
Language | 1 | 2024 | 1550 | 0.030 |
Why?
|
Tomography | 2 | 2008 | 443 | 0.030 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2012 | 645 | 0.030 |
Why?
|
Color | 1 | 2015 | 296 | 0.030 |
Why?
|
Interpersonal Relations | 1 | 2021 | 1432 | 0.030 |
Why?
|
Hospital Costs | 1 | 2020 | 956 | 0.030 |
Why?
|
Hospitals, County | 1 | 2013 | 18 | 0.030 |
Why?
|
Microsurgery | 1 | 2019 | 798 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2024 | 5311 | 0.030 |
Why?
|
Waiting Lists | 1 | 2018 | 778 | 0.030 |
Why?
|
Societies, Medical | 2 | 2015 | 3964 | 0.030 |
Why?
|
Hospital Administrators | 1 | 2013 | 57 | 0.030 |
Why?
|
Internship and Residency | 1 | 2013 | 5947 | 0.030 |
Why?
|
Glare | 1 | 2012 | 6 | 0.030 |
Why?
|
Social Class | 1 | 2021 | 2007 | 0.030 |
Why?
|
Timolol | 1 | 2012 | 51 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1359 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2015 | 592 | 0.020 |
Why?
|
Tropicamide | 1 | 2011 | 22 | 0.020 |
Why?
|
Tissue Adhesions | 1 | 2013 | 222 | 0.020 |
Why?
|
Waist Circumference | 1 | 2016 | 935 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2019 | 2120 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2007 | 7435 | 0.020 |
Why?
|
Cognition Disorders | 2 | 2003 | 3968 | 0.020 |
Why?
|
Acetazolamide | 1 | 2011 | 98 | 0.020 |
Why?
|
Tears | 1 | 2013 | 254 | 0.020 |
Why?
|
Brain Diseases | 1 | 2020 | 1551 | 0.020 |
Why?
|
Absorption | 1 | 2011 | 243 | 0.020 |
Why?
|
Walking | 1 | 2018 | 1201 | 0.020 |
Why?
|
Cost of Illness | 1 | 2021 | 1951 | 0.020 |
Why?
|
Rural Health | 1 | 2012 | 302 | 0.020 |
Why?
|
GPI-Linked Proteins | 1 | 2012 | 472 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3717 | 0.020 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2012 | 451 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4539 | 0.020 |
Why?
|
Blood Pressure Monitors | 1 | 2010 | 33 | 0.020 |
Why?
|
Quinoxalines | 1 | 2012 | 297 | 0.020 |
Why?
|
Body Weights and Measures | 1 | 2010 | 208 | 0.020 |
Why?
|
Sensory Deprivation | 1 | 2010 | 109 | 0.020 |
Why?
|
Depression | 2 | 2020 | 8234 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 3139 | 0.020 |
Why?
|
Signal Transduction | 1 | 2013 | 23621 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2015 | 812 | 0.020 |
Why?
|
Geography | 1 | 2012 | 651 | 0.020 |
Why?
|
Mortality | 1 | 2021 | 2909 | 0.020 |
Why?
|
Calcium Channels | 1 | 2013 | 622 | 0.020 |
Why?
|
Ocular Hypotension | 1 | 2009 | 23 | 0.020 |
Why?
|
Nursing Staff, Hospital | 1 | 2013 | 350 | 0.020 |
Why?
|
Gene Library | 1 | 2012 | 1065 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 2 | 2013 | 4052 | 0.020 |
Why?
|
Retinoscopy | 1 | 2009 | 27 | 0.020 |
Why?
|
Anthropometry | 1 | 2014 | 1345 | 0.020 |
Why?
|
Medication Errors | 1 | 2015 | 784 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2013 | 800 | 0.020 |
Why?
|
Medical Staff, Hospital | 1 | 2013 | 602 | 0.020 |
Why?
|
Body Constitution | 1 | 2009 | 273 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2012 | 455 | 0.020 |
Why?
|
Paresthesia | 1 | 2009 | 160 | 0.020 |
Why?
|
Surgical Wound Dehiscence | 1 | 2009 | 215 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2013 | 1101 | 0.020 |
Why?
|
Thiophenes | 1 | 2012 | 570 | 0.020 |
Why?
|
Patient Discharge | 1 | 2020 | 3467 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2012 | 1188 | 0.020 |
Why?
|
Epidemiologic Research Design | 1 | 2010 | 368 | 0.020 |
Why?
|
Random Allocation | 1 | 2011 | 2394 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 1312 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2011 | 12250 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2018 | 1945 | 0.020 |
Why?
|
Models, Theoretical | 2 | 2011 | 3561 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2020 | 5345 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 2013 | 1171 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2013 | 1512 | 0.020 |
Why?
|
Drug Combinations | 1 | 2012 | 2086 | 0.020 |
Why?
|
Phenotype | 2 | 2014 | 16718 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 2018 | 2513 | 0.020 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2005 | 92 | 0.020 |
Why?
|
Perfusion | 1 | 2010 | 1409 | 0.020 |
Why?
|
Forecasting | 1 | 2014 | 2936 | 0.020 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2005 | 177 | 0.010 |
Why?
|
Macular Edema | 1 | 2009 | 387 | 0.010 |
Why?
|
Artifacts | 1 | 2013 | 1904 | 0.010 |
Why?
|
Self Administration | 1 | 2005 | 386 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12986 | 0.010 |
Why?
|
Genetic Loci | 1 | 2013 | 2629 | 0.010 |
Why?
|
Vitamin A Deficiency | 1 | 2003 | 88 | 0.010 |
Why?
|
Eye Infections | 1 | 2003 | 63 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6067 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2012 | 2429 | 0.010 |
Why?
|
Sulfonamides | 1 | 2012 | 1982 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12536 | 0.010 |
Why?
|
Recovery of Function | 1 | 2011 | 2978 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2014 | 3986 | 0.010 |
Why?
|
Genome, Human | 1 | 2013 | 4441 | 0.010 |
Why?
|
Australia | 1 | 2004 | 1263 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2005 | 1243 | 0.010 |
Why?
|
Surgical Flaps | 1 | 2007 | 1680 | 0.010 |
Why?
|
Models, Biological | 2 | 2004 | 9464 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9532 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2012 | 12793 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7868 | 0.010 |
Why?
|
Lipids | 1 | 2007 | 3322 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 11923 | 0.010 |
Why?
|
Obesity | 1 | 2016 | 13085 | 0.010 |
Why?
|
Coronary Disease | 1 | 2004 | 5914 | 0.010 |
Why?
|